Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Element Biosciences is a multi-disciplinary life science company focused on developing disruptive DNA sequencing technology for research and diagnostic markets. The company's flagship product, the AVITI System, is a benchtop sequencer that utilizes proprietary Avidity Sequencing chemistry to deliver high-quality data at a significantly lower cost than traditional platforms. By providing increased flexibility and accessibility to genomic tools, Element Biosciences aims to accelerate scientific discovery and improve healthcare outcomes. The company serves academic research institutions, clinical laboratories, and pharmaceutical companies globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Element Labs.